BIOGEN INC. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
BIOGEN INC. (BIIB) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $0 for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-10-25.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2014-02-06
- BIOGEN INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2012-09-30 was $0.00.
- BIOGEN INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2011-12-31 was -$125.64M.
- BIOGEN INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2011-09-30 was -$61.70M.
- BIOGEN INC. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2011 was -$187.34M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month as first filed |
|---|---|---|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-10-25 | $0.00 10-Q · filed 2012-10-25 | |||
| 2011-12-31 | -$125.64M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$187.34M derived: sum of 2 quarters · filed 2014-02-06 | -$187.34M 10-K · filed 2014-02-06 | $187.34M 10-K · filed 2012-02-03 | |
| 2011-09-30 | -$61.70M 10-Q · filed 2012-10-25 | -$61.70M 10-Q · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |